Biosimilars: Some Patient And Prescriber Groups Appear To Warm Up To Arbitrary Suffixes
• By Michael Cipriano
The US FDA has approved 20 biosimilars, all but one with an arbitrary suffix. Some patient and prescriber groups are now warming up to the nomencature.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
